Clinical Trial Update: Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a corticosteroid for systemic inflammatory response syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Assiut University | Conditions: Systemic Inflammatory Response Syndrome | Phase 4 | Status: COMPLETED